z-logo
open-access-imgOpen Access
The Safety and Efficacy of Enhanced External Counterpulsation as a Treatment for Angina in Patients With Aortic Stenosis
Author(s) -
Braverman Debra L.,
Braitman Len,
Figeuredo Vincent M.
Publication year - 2013
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.22073
Subject(s) - medicine , cardiology , angina , hemodynamics , canadian cardiovascular society , blood pressure , stenosis , diastole , myocardial infarction
Background: Comorbid aortic stenosis (AS) has been considered a precaution when applying enhanced external counterpulsation (EECP) to individuals with angina due to concerns about treatment‐related hemodynamic changes. Hypothesis: The aim of this study was to determine whether EECP safely reduces symptoms of myocardial ischemia and improves hemodynamics in individuals with AS. Methods: Forty‐three patients with AS (average age, 73 years; 86% male) and 43 comparison patients without AS were chosen from a database of 1327 EECP patients. Canadian Cardiovascular Society (CCS) Functional Angina Classification, diastolic augmentation ratio, and blood pressure were measured at baseline and on completion of the course of EECP. Results: Thirty‐five of the 43 patients with AS (81%, 95% CI: 66.6% to 91.6%) and 38 of the 43 without AS (88%, 95% CI: 74.9% to 96.1%) improved in angina class ( P < 0.0001). There was no statistical difference between the percentages in patients with and without AS ( P = 0.54). CCS angina class outcome was not associated with AS severity ( P = 0.55). The percentage of patients with diastolic augmentation ratio ≥1.0 was 16.3% in both groups at baseline and improved to 39.5% in AS patients and 37.2% in non‐AS patients after EECP (both P = 0.002). The average decreases in systolic blood pressure in subjects with AS (−15 mm Hg, 95% CI: 11 to 20, P < 0.0001) and without AS (−18 mm Hg, 95% CI: 14 to 22, P < 0.0001) were similar ( P = 0.31). No major adverse cardiac events were reported. Conclusions: Angina patients with AS who undergo EECP had clinically important symptomatic and hemodynamic improvements comparable to their non‐AS counterparts. Clin. Cardiol. 2012 doi: 10.1002/clc.22073 The authors have no funding, financial relationships, or conflicts of interest to disclose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here